Clinical Trial

Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

Study acronym: SENTIRAD
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The aim of this trial is to evaluate the sentinel node policy in early stage endometrial carcinomas at intermediate and high risk of recurrence (by comparing the sentinel node policy to current initial staging protocols).
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2015-11-04; most recent amendment 2026-03-16.
Status change: Recruiting → Active, Not Recruiting 2019-09-17
Status change: Not Yet Recruiting → Recruiting 2016-02-10
Trial Details
NCT Number NCT02598219
Lead Sponsor Centre Oscar Lambret
Collaborators: National Cancer Institute, France, Institut National de la Santé Et de la Recherche Médicale, France, Canceropôle Nord Ouest
Conditions Non Endometrioid Carcinoma, Endometrioid Carcinoma
Enrollment 262 participants
Start Date 2015-11
Primary Completion 2024-10 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2026-03-18